SCHEMBL1786392

SCHEMBL1786392

CCc1cccc(Sc2cccc(CC)c2-c2ccccc2)c1-c1ccccc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GABRA1 P14867 2/20 0.39
▸ GABRB2 P47870 2/20 0.39
▸ MAPT P10636 3/20 0.38
▸ KDM4E B2RXH2 2/20 0.38
▸ ALDH1A1 P00352 2/20 0.38
▸ CYP2C9 P11712 2/20 0.38
▸ HPGD P15428 2/20 0.38
▸ CYP2C19 P33261 2/20 0.38
▸ CYP1A2 P05177 1/20 0.38
▸ CYP2D6 P10635 1/20 0.38
▸ TSHR P16473 1/20 0.38
▸ HSD17B10 Q99714 1/20 0.38
▸ MMP2 P08253 1/20 0.37
▸ MMP9 P14780 1/20 0.37
▸ MMP12 P39900 1/20 0.37
▸ MAPK1 P28482 2/20 0.37
▸ NSD2 O96028 1/20 0.37
▸ LMNA P02545 4/20 0.37
▸ HTT P42858 1/20 0.37
▸ IFNAR1 P17181 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1786275 0.89 APOBEC3G (0.41) GABRA1GABRB2MAPTKDM4EALDH1A1
SCHEMBL1786280 0.85 GABRA1 (0.36) GABRA1GABRB2MAPTKDM4EALDH1A1
SCHEMBL29005808 0.82 CYSLTR2 (0.38) CYP2C9CYP2D6DHFR
SCHEMBL29005743 0.80 LIPG (0.46) DHFR
SCHEMBL27759679 0.77 MAPT (0.48) GABRA1GABRB2MAPTKDM4EALDH1A1
SCHEMBL74169 0.77 SLC6A2 (0.47) GABRA1GABRB2ALDH1A1MAPK1LMNA
SCHEMBL8459429 0.76 PDCD1 (0.50) GABRA1GABRB2MAPTKDM4EALDH1A1
SCHEMBL980893 0.74 GABRA1 (0.50) GABRA1GABRB2KDM4EALDH1A1HPGD
SCHEMBL30481171 0.74 GABRA1 (0.40) GABRA1GABRB2MAPTKDM4EALDH1A1
SCHEMBL29047890 0.74 GABRA1 (0.40) GABRA1GABRB2MAPTKDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112979917-B Isocyanate composition, method for producing isocyanate composition, and method for producing isocyanate polymer 旭化成株式会社 2023-04-25 — — CN disclosed
EP-2323975-B1 MULTI-RING ANTIOXIDANTS WITH ANTIWEAR PROPERTIES SI GROUP INC (US) 2019-04-24 — — EP disclosed
US-9796939-B2 Multi-ring antioxidants with antiwear properties SI GROUP, INC. (US) 2017-10-24 — — US disclosed
US-20140038871-A1 MULTI-RING ANTIOXIDANTS WITH ANTIWEAR PROPERTIES ALBEMARLE CORPORATION (US) 2014-02-06 — — US disclosed
US-8580718-B2 Multi-ring antioxidants with antiwear properties ALBERMARLE CORPORATION (US) 2013-11-12 — — US disclosed
US-20110124540-A1 MULTI-RING ANTIOXIDANTS WITH ANTIWEAR PROPERTIES ALBEMARLE CORPORATION (US) 2011-05-26 — — US disclosed
EP-2323975-A2 MULTI-RING ANTIOXIDANTS WITH ANTIWEAR PROPERTIES Albemarle Corporation (US) 2011-05-25 — — EP disclosed
WO-2010011523-A2 MULTI-RING ANTIOXIDANTS WITH ANTIWEAR PROPERTIES ALBEMARLE CORPORATION (US) 2010-01-28 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110124540-A1 MULTI-RING ANTIOXIDANTS WITH ANTIWEAR PROPERTIES GSR, CBR1, SOD1 GABRA1 2545/4885GABRB2 2611/4885MAPT 2663/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback